Link to the article: https://www.nature.com/articles/s41380-026-03610-7#MOESM1

Big dataset, some interesting claims, unsure if the swings they are taking with this truly line up with what the actual data analysis show.

Supplemental materials show a lot of increased risk for diagnosis of autism with adjusted hazard ratios in race, ethnicity, Social vulnerability index, etc etc. across multiple drugs, as well as increased risk with non sterol pathway drugs. would love to hear thoughts.